MovDisordV3, Main, Exploration, bibRecord, 002092

Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs

Identifieur interne : 002092 ( Main/Exploration ); précédent : 002091; suivant : 002093

Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs

Auteurs : Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2009-06-15.

RBID : ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4B

Descripteurs français

Pascal (Inist)
- Crise oculogyre, Dystonie, Neuroleptique, Pathologie du système nerveux, Récepteur dopaminergique, Récidivant, Traitement.

English descriptors

KwdEn :
- Adult, Child, Disease Progression, Dopamine Antagonists (adverse effects), Dopamine receptor, Dyskinesia, Drug-Induced, Dystonia, Dystonia (chemically induced), Electroencephalography (methods), Female, Humans, Male, Nervous system diseases, Neuroleptic, Ocular Motility Disorders (chemically induced), Oculogyric crisis, Recurrent, Treatment, acute dystonic reaction, antidopaminergic treatment, dystonia, neuroleptics, oculogyric crisis.
MESH :
- chemical , adverse effects : Dopamine Antagonists.
- chemically induced : Dystonia, Ocular Motility Disorders.
- methods : Electroencephalography.
- Adult, Child, Disease Progression, Dyskinesia, Drug-Induced, Female, Humans, Male.

Abstract

Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society

Url:

https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/pdf

DOI: 10.1002/mds.22532

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title>
<author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name>
</author>
<author><name sortKey="Udani, Vrajesh" sort="Udani, Vrajesh" uniqKey="Udani V" first="Vrajesh" last="Udani">Vrajesh Udani</name>
</author>
<author><name sortKey="Sankhla, Charulata Sawant" sort="Sankhla, Charulata Sawant" uniqKey="Sankhla C" first="Charulata Sawant" last="Sankhla">Charulata Sawant Sankhla</name>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22532</idno>
<idno type="url">https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E56</idno>
<idno type="wicri:Area/Istex/Curation">000E56</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C94</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Schneider S:recurrent:acute:dystonic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19412963</idno>
<idno type="wicri:Area/PubMed/Corpus">001D22</idno>
<idno type="wicri:Area/PubMed/Curation">001D22</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C00</idno>
<idno type="wicri:Area/Ncbi/Merge">002655</idno>
<idno type="wicri:Area/Ncbi/Curation">002655</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002655</idno>
<idno type="wicri:Area/Main/Merge">002953</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:09-0302004</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E37</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001E82</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D27</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Schneider S:recurrent:acute:dystonic</idno>
<idno type="wicri:Area/Main/Merge">002E24</idno>
<idno type="wicri:Area/Main/Curation">002092</idno>
<idno type="wicri:Area/Main/Exploration">002092</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title>
<author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Udani, Vrajesh" sort="Udani, Vrajesh" uniqKey="Udani V" first="Vrajesh" last="Udani">Vrajesh Udani</name>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai</wicri:regionArea>
<wicri:noRegion>Mumbai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sankhla, Charulata Sawant" sort="Sankhla, Charulata Sawant" uniqKey="Sankhla C" first="Charulata Sawant" last="Sankhla">Charulata Sawant Sankhla</name>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai</wicri:regionArea>
<wicri:noRegion>Mumbai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-06-15">2009-06-15</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1226">1226</biblScope>
<biblScope unit="page" to="1229">1229</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</idno>
<idno type="DOI">10.1002/mds.22532</idno>
<idno type="ArticleID">MDS22532</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Child</term>
<term>Disease Progression</term>
<term>Dopamine Antagonists (adverse effects)</term>
<term>Dopamine receptor</term>
<term>Dyskinesia, Drug-Induced</term>
<term>Dystonia</term>
<term>Dystonia (chemically induced)</term>
<term>Electroencephalography (methods)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Nervous system diseases</term>
<term>Neuroleptic</term>
<term>Ocular Motility Disorders (chemically induced)</term>
<term>Oculogyric crisis</term>
<term>Recurrent</term>
<term>Treatment</term>
<term>acute dystonic reaction</term>
<term>antidopaminergic treatment</term>
<term>dystonia</term>
<term>neuroleptics</term>
<term>oculogyric crisis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term>
<term>Ocular Motility Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electroencephalography</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Child</term>
<term>Disease Progression</term>
<term>Dyskinesia, Drug-Induced</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Crise oculogyre</term>
<term>Dystonie</term>
<term>Neuroleptique</term>
<term>Pathologie du   système nerveux</term>
<term>Récepteur dopaminergique</term>
<term>Récidivant</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Inde</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name>
</region>
<name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</country>
<country name="Inde"><noRegion><name sortKey="Udani, Vrajesh" sort="Udani, Vrajesh" uniqKey="Udani V" first="Vrajesh" last="Udani">Vrajesh Udani</name>
</noRegion>
<name sortKey="Sankhla, Charulata Sawant" sort="Sankhla, Charulata Sawant" uniqKey="Sankhla C" first="Charulata Sawant" last="Sankhla">Charulata Sawant Sankhla</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002092 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002092 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4B
   |texte=   Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs

Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.